U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.
Melanoma, the most aggressive type of skin cancer, is the leading cause of death from skin cancer. Patients with stage III melanoma are generally treated by surgery to remove the melanoma skin lesions and the nearby lymph nodes.
Indian Immunologicals Ltd (IIL), a leading biological company inaugurated its new bovine serum manufacturing facility in New Zealand.
Strengthening its over the counter (OTC) portfolio, Pharma major Dr. Reddy's Laboratories on Monday announced the launch of Nise D spray, which offers quick and targeted pain killing.
Sun Pharmaceutical Industries Ltd.successfully completed cash tender offered by by Thea Acquisition Corp. (“Thea”), an indirect wholly owned subsidiary of Sun Pharma, for all outstanding shares of common stock of InSite Vision Incorporated (OTCBB: INSV, InSite), which expired at 12:00 midnight, New York City time, (the end of the day) on Tuesday, October 27, 2015.
16% local currency operating profit growth adjusted for the NNIT divestment
Sales increased by 23% in Danish kroner and by 9% in local currencies to DKK 79.1 billion.
- 50% of ALF cases happen due to Hepatitis A&E, unavailability of clean potable water
- ALF mortality has come down to 20 % from 80 % in last 10 years due to advancement in liver intensive care and liver transplantation of ALF patients.
(NewsVoir); The expert team of Department of Hepatology at Global Hospitals - one of the fastest growing chains of multi-super speciality, multi-organ transplant and quaternary care hospitals in Mumbai, shared their experience in treating and managing Acute Liver Failure patients medically and through transplantation.
[adsense:336x280:8701650588]
Dabur India on announced 18.7 percent increase in its net consolidated profit at Rs.341.1 crore for the quarter ended September 30 as against Rs.287.5 crore in the year-ago period.
Non-life insurer Future Generali India Insurance Company Ltd. hopes to increase its retail health insurance business with its new product, a senior official said on Wednesday.
Natco Pharma has launched the first licensed generic version of ledipasvir+sofosbuvir combination in Nepal, under its brand name Hepcinat LP.
[adsense:336x280:8701650588]
Max Healthcare (MHC) today announced a partnership with Smart Group wherein MHC would acquire 51% stake in Saket City Hospital Pvt. Ltd., from Smart Health City Pte Ltd, the Singapore based BK Modi Group company which manages and operates the Delhi based Saket City Hospital (SCH). The transaction is subject to confirmatory diligence, requisite regulatory approvals and other customary conditions.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
